{"id":47619,"date":"2022-10-17T15:47:34","date_gmt":"2022-10-17T19:47:34","guid":{"rendered":"https:\/\/wfh.org\/article\/speaker\/david-page\/"},"modified":"2022-10-17T16:08:06","modified_gmt":"2022-10-17T20:08:06","slug":"david-page","status":"publish","type":"speaker","link":"https:\/\/wfh.org\/es\/article\/speaker\/david-page\/","title":{"rendered":"David Page"},"content":{"rendered":"
David Page
\nDirector of Health Policy
\nThe Canadian Hemophilia Society (CHS)<\/p>\n","protected":false},"excerpt":{"rendered":"
David Page is Director of Health Policy for the Canadian Hemophilia Society (CHS). His principal role is to advocate for access to optimal comprehensive care and the most efficacious coagulation therapies in Canada. He served as a volunteer with the CHS from 1982 to 2001, including a 2-year term as President in the 1990s. In 2001, he left the field of teaching and educational publishing to take a staff position with the CHS. He was National Executive Director from 2006 to 2017. David served on the Quebec Hemovigilance Committee advising the Minister of Health on blood safety issues from 1998 to 2006, including four years as president. He has been a member of the H\u00e9ma-Qu\u00e9bec (Quebec\u2019s blood establishment) Safety Committee since 1999 and is now its chairperson. David served on the Executive Committee of the World Federation of Hemophilia from 2000 to 2008 and was chair of its Coagulation Products Safety, Supply and Access Committee from 2001 to 2016. David has severe factor IX deficiency.<\/p>\n","protected":false},"featured_media":73334,"template":"","meta":{"inline_featured_image":false},"speaker-type":[268,270],"class_list":["post-47619","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","speaker-type-all-speakers-es","speaker-type-speakers-es"],"yoast_head":"\n